JPS5331694A - 3-aminopyrazolo(3,4- )pyrimidine derivatives and their preparation - Google Patents

3-aminopyrazolo(3,4- )pyrimidine derivatives and their preparation

Info

Publication number
JPS5331694A
JPS5331694A JP10519176A JP10519176A JPS5331694A JP S5331694 A JPS5331694 A JP S5331694A JP 10519176 A JP10519176 A JP 10519176A JP 10519176 A JP10519176 A JP 10519176A JP S5331694 A JPS5331694 A JP S5331694A
Authority
JP
Japan
Prior art keywords
aminopyrazolo
preparation
pyrimidine derivatives
pyrimidine
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10519176A
Other languages
Japanese (ja)
Other versions
JPS6032638B2 (en
Inventor
Tatsuhiko Naka
Sumiyasu Furukawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP10519176A priority Critical patent/JPS6032638B2/en
Publication of JPS5331694A publication Critical patent/JPS5331694A/en
Publication of JPS6032638B2 publication Critical patent/JPS6032638B2/en
Expired legal-status Critical Current

Links

Abstract

PURPOSE: 3-Aminopyrazolo [3,4-d] pyrimidine derivatives of formula I (R1 - R3 are H or alkyl; R3 is H, alkyl, aryl, aralkyl or acyl; R5 is H, acyl, alkylcarbamoyl or alkylthiocarbamoyl) and their salts, e.g. 3-methylamino-5,7-diethylpyrazolo [3,4-d] pyrimidine.
COPYRIGHT: (C)1978,JPO&Japio
JP10519176A 1976-09-01 1976-09-01 3-Aminopyrazolo[3,4-d]pyrimidine derivative Expired JPS6032638B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10519176A JPS6032638B2 (en) 1976-09-01 1976-09-01 3-Aminopyrazolo[3,4-d]pyrimidine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10519176A JPS6032638B2 (en) 1976-09-01 1976-09-01 3-Aminopyrazolo[3,4-d]pyrimidine derivative

Publications (2)

Publication Number Publication Date
JPS5331694A true JPS5331694A (en) 1978-03-25
JPS6032638B2 JPS6032638B2 (en) 1985-07-29

Family

ID=14400771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10519176A Expired JPS6032638B2 (en) 1976-09-01 1976-09-01 3-Aminopyrazolo[3,4-d]pyrimidine derivative

Country Status (1)

Country Link
JP (1) JPS6032638B2 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615082A (en) * 1984-06-18 1986-01-10 Takeda Chem Ind Ltd 3-aminopyrazolo(3,4-d)pyrimidine derivative
US4912104A (en) * 1987-08-31 1990-03-27 Takeda Chemical Industries, Ltd. Tricyclic fused pryimidine derivatives, and their use as pharmaceuticals
EP2023729A2 (en) * 2006-06-06 2009-02-18 Intra-Cellular Therapies, Inc. Organic compounds
JP2012510991A (en) * 2008-12-06 2012-05-17 イントラ−セルラー・セラピーズ・インコーポレイテッド Organic compounds
JP2012510996A (en) * 2008-12-06 2012-05-17 イントラ−セルラー・セラピーズ・インコーポレイテッド Organic compounds
JP2012510995A (en) * 2008-12-06 2012-05-17 イントラ−セルラー・セラピーズ・インコーポレイテッド Organic compounds
US8273750B2 (en) 2005-06-06 2012-09-25 Takeda Pharmaceutical Company Limited Organic compounds
US8846693B2 (en) 2007-12-06 2014-09-30 Intra-Cellular Therapies, Inc. Optionally substituted pyrazolo[3,4-d]pyrimidine-4,6-diones
US9006258B2 (en) 2006-12-05 2015-04-14 Intra-Cellular Therapies, Inc. Method of treating female sexual dysfunction with a PDE1 inhibitor
US9073936B2 (en) 2013-03-15 2015-07-07 Intra-Cellular Therapies, Inc. Organic compounds
US9157906B2 (en) 2001-08-31 2015-10-13 The Rockefeller University Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
US9198924B2 (en) 2006-11-13 2015-12-01 Intra-Cellular Therapies, Inc. Organic compounds
US9371327B2 (en) 2010-05-31 2016-06-21 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
US9434730B2 (en) 2010-05-31 2016-09-06 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
US9468637B2 (en) 2009-05-13 2016-10-18 Intra-Cellular Therapies, Inc. Organic compounds
US9545406B2 (en) 2013-03-15 2017-01-17 Intra-Cellular Therapies, Inc. Method of treating a CNS injury with a PDE1 inhibitor
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
US9556185B2 (en) 2010-05-31 2017-01-31 Intra-Cellular Therapies, Inc. Organic compounds
US9605041B2 (en) 2009-08-05 2017-03-28 Intra-Cellular Therapies, Inc. Regulatory proteins and inhibitors
US9763948B2 (en) 2010-05-31 2017-09-19 Intra-Cellular Therapies, Inc. PDE1 inhibitory compounds and methods
US9801882B2 (en) 2013-02-17 2017-10-31 Intra-Cellular Therapies, Inc. Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases
US9884872B2 (en) 2014-06-20 2018-02-06 Intra-Cellular Therapies, Inc. Organic compounds
US10131671B2 (en) 2014-08-07 2018-11-20 Intra-Cellular Therapies, Inc. Organic compounds
US10150774B2 (en) 2014-09-17 2018-12-11 Intra-Cellular Therapies, Inc. Compounds and methods
US10285992B2 (en) 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
US11291666B2 (en) 2016-09-12 2022-04-05 Intra-Cellular Therapies, Inc. Uses
US11464781B2 (en) 2009-02-25 2022-10-11 Intra-Cellular Therapies, Inc. PDE1 inhibitors for ophthalmic disorders
US11759465B2 (en) 2018-01-31 2023-09-19 Intra-Cellular Therapies, Inc. Uses

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0113712B2 (en) * 1984-06-18 1989-03-07 Takeda Chemical Industries Ltd
JPS615082A (en) * 1984-06-18 1986-01-10 Takeda Chem Ind Ltd 3-aminopyrazolo(3,4-d)pyrimidine derivative
US4912104A (en) * 1987-08-31 1990-03-27 Takeda Chemical Industries, Ltd. Tricyclic fused pryimidine derivatives, and their use as pharmaceuticals
US9157906B2 (en) 2001-08-31 2015-10-13 The Rockefeller University Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
US8273750B2 (en) 2005-06-06 2012-09-25 Takeda Pharmaceutical Company Limited Organic compounds
US9000001B2 (en) 2005-06-06 2015-04-07 Intra-Cellular Therapies, Inc. Organic compounds
US9624230B2 (en) 2005-06-06 2017-04-18 Intra-Cellular Therapies, Inc. Organic compounds
JP2009539872A (en) * 2006-06-06 2009-11-19 イントラ−セルラー・セラピーズ・インコーポレイテッド Organic compounds
US9255099B2 (en) 2006-06-06 2016-02-09 Intra-Cellular Therapies, Inc. Pyrazolo[3,4-D]pyrimidine-4,6(5H,7H)-diones as phosphodiesterase 1 inhibitors
AU2007256633B2 (en) * 2006-06-06 2013-09-12 Intra-Cellular Therapies, Inc. Organic compounds
JP2014012729A (en) * 2006-06-06 2014-01-23 Intra-Cellular Therapies Inc Organic compounds
EP2023729A4 (en) * 2006-06-06 2010-07-14 Intra Cellular Therapies Inc Organic compounds
EP2023729A2 (en) * 2006-06-06 2009-02-18 Intra-Cellular Therapies, Inc. Organic compounds
US9198924B2 (en) 2006-11-13 2015-12-01 Intra-Cellular Therapies, Inc. Organic compounds
US9006258B2 (en) 2006-12-05 2015-04-14 Intra-Cellular Therapies, Inc. Method of treating female sexual dysfunction with a PDE1 inhibitor
US8846693B2 (en) 2007-12-06 2014-09-30 Intra-Cellular Therapies, Inc. Optionally substituted pyrazolo[3,4-d]pyrimidine-4,6-diones
US8697710B2 (en) 2008-12-06 2014-04-15 Intra-Cellular Therapies, Inc. Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones
US8927556B2 (en) 2008-12-06 2015-01-06 Intra-Cellular Therapies, Inc. 1H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compounds
US8859564B2 (en) 2008-12-06 2014-10-14 Intra-Cellular Therapies, Inc. Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1
JP2012510995A (en) * 2008-12-06 2012-05-17 イントラ−セルラー・セラピーズ・インコーポレイテッド Organic compounds
JP2012510996A (en) * 2008-12-06 2012-05-17 イントラ−セルラー・セラピーズ・インコーポレイテッド Organic compounds
JP2012510991A (en) * 2008-12-06 2012-05-17 イントラ−セルラー・セラピーズ・インコーポレイテッド Organic compounds
US9487527B2 (en) 2008-12-06 2016-11-08 Intra-Cellular Therapies, Inc. Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase I
US11464781B2 (en) 2009-02-25 2022-10-11 Intra-Cellular Therapies, Inc. PDE1 inhibitors for ophthalmic disorders
US9468637B2 (en) 2009-05-13 2016-10-18 Intra-Cellular Therapies, Inc. Organic compounds
US10238660B2 (en) 2009-05-13 2019-03-26 Intra-Cellular Therapies, Inc. Organic compounds
US10010553B2 (en) 2009-05-13 2018-07-03 Intra-Cellular Therapies, Inc. Organic compounds
US9605041B2 (en) 2009-08-05 2017-03-28 Intra-Cellular Therapies, Inc. Regulatory proteins and inhibitors
US9434730B2 (en) 2010-05-31 2016-09-06 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
US9556185B2 (en) 2010-05-31 2017-01-31 Intra-Cellular Therapies, Inc. Organic compounds
US9371327B2 (en) 2010-05-31 2016-06-21 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
US9763948B2 (en) 2010-05-31 2017-09-19 Intra-Cellular Therapies, Inc. PDE1 inhibitory compounds and methods
US9801882B2 (en) 2013-02-17 2017-10-31 Intra-Cellular Therapies, Inc. Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases
US10398698B2 (en) 2013-02-17 2019-09-03 Intra-Cellular Therapies, Inc. Uses
US10682355B2 (en) 2013-03-15 2020-06-16 Intra-Cellular Therapies, Inc. Uses
US9545406B2 (en) 2013-03-15 2017-01-17 Intra-Cellular Therapies, Inc. Method of treating a CNS injury with a PDE1 inhibitor
US9598426B2 (en) 2013-03-15 2017-03-21 Intra-Cellular Therapies, Inc. Organic compounds
US11504372B2 (en) 2013-03-15 2022-11-22 Intra-Cellular Therapies, Inc. Uses
US9073936B2 (en) 2013-03-15 2015-07-07 Intra-Cellular Therapies, Inc. Organic compounds
US10183023B2 (en) 2013-03-15 2019-01-22 Intra-Cellular Therapies, Inc. Uses
US9556186B2 (en) 2013-03-15 2017-01-31 Intra-Cellular Therapies, Inc. Organic compounds
US9884872B2 (en) 2014-06-20 2018-02-06 Intra-Cellular Therapies, Inc. Organic compounds
US10285992B2 (en) 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
US11166956B2 (en) 2014-08-07 2021-11-09 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors
US10131671B2 (en) 2014-08-07 2018-11-20 Intra-Cellular Therapies, Inc. Organic compounds
US10150774B2 (en) 2014-09-17 2018-12-11 Intra-Cellular Therapies, Inc. Compounds and methods
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
US11291666B2 (en) 2016-09-12 2022-04-05 Intra-Cellular Therapies, Inc. Uses
US11759465B2 (en) 2018-01-31 2023-09-19 Intra-Cellular Therapies, Inc. Uses
US11839614B2 (en) 2018-01-31 2023-12-12 Intra-Cellular Therapies, Inc. Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression

Also Published As

Publication number Publication date
JPS6032638B2 (en) 1985-07-29

Similar Documents

Publication Publication Date Title
JPS5331694A (en) 3-aminopyrazolo(3,4- )pyrimidine derivatives and their preparation
JPS5412372A (en) Thiazolidine derivative and its preparation
JPS5395977A (en) 1,4-dihydropyrimidine compounds and process for their preparation
JPS5331676A (en) Uracil derivatives and their preparation
JPS5312876A (en) Pyrimidine derivatives, their preparation and fungicides containing the same for agriculture
JPS5331674A (en) 5-fluorouracil derivatives and their preparation
JPS5432466A (en) Thiazolidine derivatives and their preparation
JPS5427578A (en) 1-carboxyalkylcarbamoyl-5-fluorouracil derivatives and their preparation
JPS5368800A (en) Cycloalkyl substd. pyrrolotriazolopyrimidine derivatives
JPS5353698A (en) Pyrrolotriazolopyrimidine derivatives and their preparation
AU515998B2 (en) Preparation of omega dialkoxycarboxylic acid derivatives
JPS5344572A (en) 5-alkoxy-picolic acid, its preparation and hypotensives containing the same
JPS5318562A (en) Oxyindole derivatives
JPS525797A (en) Preparation of tetrahydropyrido pyrimidinone derivatives
JPS5356692A (en) Pyridopyrimidine derivatives and their preparation
JPS5344591A (en) Preparation of adenine derivatives
JPS51146474A (en) Process for preparing piperidylbenzimidazole derivatives
JPS5387330A (en) Novel thiohydroxymate derivative, its preparation and bactericideand herbicide containing the same
JPS5350194A (en) 77 44*alkanesulfoneamidephenyl**55oxoimidazolidinyl 33methyll 33cephemm44ca rboxlic acid derivatives
JPS51148025A (en) Insecticides, miticides and their preparation
JPS52144647A (en) Beta-oxysulfoxide derivatives and their preparation
JPS52122387A (en) 7alpha-methoxycephalosporin derivatives and their preparation
JPS5384935A (en) N-substitute benzanilides and bactericides containing the same
JPS5363382A (en) Nicotinic acid esters and their preparation
JPS5379888A (en) 2,2- or 3,3-dl-substituted-imidazo 1,3